Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open-Label Study On The Effects Of Human Secretin For Injection (CHIROSTIM) On Pancreatic Fluid Composition In Normal Human Volunteer Participants

NCT07285863 is registered in ClinicalTrials.gov with Mayo Clinic as lead sponsor.

NCT NCT07285863
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07285863 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open-Label Study On The Effects Of Human Secretin For Injection (CHIROSTIM) On Pancreatic Fluid Composition In Normal Human Volunteer Participants
Lead sponsor
Mayo Clinic
Phase
Phase 4
Overall status
Recruiting
Start date
March 11, 2026
Completion date
March 31, 2028
Enrollment
24 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

chronic pancreatitis, exocrine pancreatic insufficiency